NewEdge Advisors’s Acadia Pharmaceuticals ACAD Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$2.43K	Sell	109 -100	-48%	-$2.39K	﹤0.01%	3766
2025 Q4	$5.58K	Hold	209	–	–	﹤0.01%	3646
2025 Q3	$4.46K	Hold	209	–	–	﹤0.01%	3571
2025 Q2	$4.51K	Hold	209	–	–	﹤0.01%	3435
2025 Q1	$3.47K	Hold	209	–	–	﹤0.01%	3396
2024 Q4	$3.83K	Hold	209	–	–	﹤0.01%	3303
2024 Q3	$3.21K	Hold	209	–	–	﹤0.01%	3296
2024 Q2	$3.4K	Hold	209	–	–	﹤0.01%	3205
2024 Q1	$3.86K	Hold	209	–	–	﹤0.01%	3226
2023 Q4	$6.54K	Buy	209 +109	+109%	+$2.6K	﹤0.01%	3024
2023 Q3	$2.08K	Sell	100 -100	-50%	-$2.72K	﹤0.01%	3037
2023 Q2	$4.79K	Hold	200	–	–	﹤0.01%	2834
2023 Q1	$3.76K	Sell	200 -209	-51%	-$3.98K	﹤0.01%	2867
2022 Q4	$3.33K	Buy	+409	New	+$6.39K	﹤0.01%	2716